Ida Grundberg
Chief Tech/Sci/R&D Officer en OLINK HOLDING AB .
Perfil
Ida Grundberg is currently the Chief Scientific Officer at Olink Holding AB since 2019.
Prior to this, she worked at Olink Proteomics AB from 2011 to 2019 as the Head of Business Development, VP of Sales & Marketing.
She obtained a doctorate degree from the University of Uppsala and completed her undergraduate and graduate studies at Umea Universitet.
Cargos activos de Ida Grundberg
| Empresas | Cargo | Inicio |
|---|---|---|
| OLINK HOLDING AB | Chief Tech/Sci/R&D Officer | 01/09/2019 |
Antiguos cargos conocidos de Ida Grundberg.
| Empresas | Cargo | Fin |
|---|---|---|
Olink Proteomics AB
 Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden. | Sales & Marketing | 01/09/2019 |
Formación de Ida Grundberg.
| University of Uppsala | Doctorate Degree |
| Umea Universitet | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| OLINK HOLDING AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden. | Commercial Services |
- Bolsa de valores
- Insiders
- Ida Grundberg
